Health Condition 1: null- Bacterial conjunctivitis
Conditions
Interventions
Intervention1: Topical Besifloxacin 0.6% suspension one drop three times a day instilled in the affected eye for 5 days: Topical Moxifloxacin 0.5%solution one drop three times a day instilled in the a
Sponsors
C K Devipriya
Eligibility
Inclusion criteria
Inclusion criteria: 1 Age Above 18 years both male and female 2 Patients who are clinically diagnosed as bacterial conjunctivitis 3 Patients with visual acuity >6/60 in both eyes 4 Patients willing to give a written informed consent
Exclusion criteria
Exclusion criteria: 1 Patients with other form of conjunctivitis like viral or allergic conjunctivitis 2 Patient already using any topical eyedrops 3 Patient with any history of ocular surgery within 6 weeks of study entry 4 Patients with iritis,active ulcerative keratitis recurrent corneal erosion syndrome 5 Patients with history of drug allergy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the efficacy of Topical Besifloxacin0.6% versus Moxifloxacin 0.5% in bacterial conjunctivitisTimepoint: The clinical efficacy was measured as cumulative sum score of seven key signs and symptoms of acute bacterial conjunctivitis Time points 5 days | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the treatment outcome and tolerability of study medication.Timepoint: 4 step scale.Time points 10 days | — |
Countries
India
Contacts
Public ContactJ Komathi
Chengalpattu Medical College
Outcome results
None listed